CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
103 hedge funds and large institutions have $44.5M invested in Carisma Therapeutics in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
24% less call options, than puts
Call options by funds: $2.09M | Put options by funds: $2.75M
85% less capital invested
Capital invested by funds: $305M → $44.5M (-$261M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
103
Holding in Top 10
–
Calls
$2.09M
Puts
$2.75M
Top Buyers
| 1 | +$1.35M | |
| 2 | +$996K | |
| 3 | +$563K | |
| 4 |
Jane Street
New York
|
+$512K |
| 5 |
Morgan Stanley
New York
|
+$367K |
Top Sellers
| 1 | -$7.66M | |
| 2 | -$3.29M | |
| 3 | -$3.03M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.31M |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$1.2M |